IDA total vs Spain: Access to anti-retroviral drugs, male
IDA total
78.2%
in 2024
Spain
91.0%
in 2022
IDA total rank
11th
Spain rank
12th
Access to anti-retroviral drugs, male over time
- IDA total
- Spain
How they compare
Spain currently reports 91.0% against 78.2% in IDA total, a difference of 12.8%.
That makes Spain's figure about 1.2 times IDA total's.
Across all 23 years both countries report, Spain has been ahead every year.
IDA total ranks 11th and Spain ranks 12th of 19 groups.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 41.7% | 36.1% | Spain |
| 2010s | 39.4% | 73.4% | 34.0% | Spain |
| 2020s | 67.6% | 88.7% | 21.1% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA total or Spain?
- Spain, at 91.0% against 78.2% in IDA total as of 2022.
- What is the difference in access to anti-retroviral drugs, male between IDA total and Spain?
- 12.8%, with Spain ahead.
- How many years of comparable data are there for IDA total and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do IDA total and Spain rank globally for access to anti-retroviral drugs, male?
- IDA total ranks 11th and Spain ranks 12th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.